tiprankstipranks
Trending News
More News >
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP

Crispr Therapeutics AG (CRSP) Revenue

Compare
9,444 Followers

Crispr Therapeutics AG Revenue

Crispr Therapeutics AG had a revenue of 865.00K in the quarter ending Mar 31, 2025, with -97.53%. This bring the company's revenue in the last twelve months to 36.98M, Decreased 0.99%. In the fiscal year ending Dec 31, 2024, Crispr Therapeutics AG had annual revenue of 35.00M with -90.57% growth.
Revenue (ttm)
36.98M
Revenue Growth
-86.13%
P/S Ratio
109.19
Revenue/Employee
$89,059
Employees
393
Market Cap
$3.82B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
35.00M-336.21M-90.57%
Dec 31, 2023
371.21M370.77M+85,038.99%
Dec 31, 2022
436.00K-912.64M-99.95%
Dec 31, 2021
913.08M912.54M+168,054.88%
Dec 31, 2020
543.00K-289.05M-99.81%
Dec 31, 2019
289.59M286.47M+9,169.85%
Dec 31, 2018
3.12M-37.87M-92.38%
Dec 31, 2017
41.00M35.83M+693.90%
Dec 31, 2016
5.16M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis